Truist Financial Increases DaVita (NYSE:DVA) Price Target to $175.00

DaVita (NYSE:DVA) had its target price increased by Truist Financial from $165.00 to $175.00 in a note issued to investors on Monday, Benzinga reports. The firm currently has a “hold” rating on the stock. Truist Financial’s target price points to a potential upside of 13.38% from the stock’s current price.

Several other equities analysts also recently issued reports on DVA. UBS Group upped their target price on DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. TD Cowen lifted their target price on DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a report on Wednesday, July 24th. Finally, Bank of America increased their price target on shares of DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $159.00.

DaVita Price Performance

Shares of NYSE DVA opened at $154.35 on Monday. DaVita has a fifty-two week low of $71.51 and a fifty-two week high of $166.04. The company has a market cap of $12.95 billion, a PE ratio of 17.54, a P/E/G ratio of 0.92 and a beta of 0.87. The company has a debt-to-equity ratio of 9.94, a quick ratio of 1.12 and a current ratio of 1.16. The business has a 50-day simple moving average of $152.87 and a two-hundred day simple moving average of $143.27.

DaVita (NYSE:DVA) last released its earnings results on Tuesday, August 6th. The company reported $2.59 EPS for the quarter, topping analysts’ consensus estimates of $2.47 by $0.12. DaVita had a net margin of 6.86% and a return on equity of 77.00%. The company had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.15 billion. During the same period last year, the business earned $2.08 EPS. DaVita’s revenue for the quarter was up 6.2% on a year-over-year basis. As a group, equities analysts expect that DaVita will post 9.99 EPS for the current fiscal year.

Insider Transactions at DaVita

In related news, insider Kathleen Alyce Waters sold 7,857 shares of DaVita stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the completion of the transaction, the insider now directly owns 83,011 shares in the company, valued at approximately $12,137,038.31. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, CEO Javier Rodriguez sold 50,000 shares of the firm’s stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the sale, the chief executive officer now directly owns 837,835 shares in the company, valued at $138,284,666.75. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Kathleen Alyce Waters sold 7,857 shares of DaVita stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the completion of the sale, the insider now directly owns 83,011 shares in the company, valued at $12,137,038.31. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 173,482 shares of company stock worth $27,387,069 over the last quarter. 2.00% of the stock is currently owned by insiders.

Hedge Funds Weigh In On DaVita

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DVA. SG Americas Securities LLC boosted its stake in shares of DaVita by 196.9% in the first quarter. SG Americas Securities LLC now owns 29,733 shares of the company’s stock worth $4,105,000 after acquiring an additional 19,719 shares during the last quarter. Bessemer Group Inc. grew its holdings in shares of DaVita by 2,335.6% during the first quarter. Bessemer Group Inc. now owns 10,741 shares of the company’s stock worth $1,483,000 after buying an additional 10,300 shares in the last quarter. Forsta AP Fonden grew its holdings in shares of DaVita by 50.3% during the first quarter. Forsta AP Fonden now owns 23,600 shares of the company’s stock worth $3,258,000 after buying an additional 7,900 shares in the last quarter. Fox Hill Wealth Management raised its position in shares of DaVita by 138.4% in the first quarter. Fox Hill Wealth Management now owns 15,734 shares of the company’s stock valued at $2,172,000 after buying an additional 9,135 shares during the last quarter. Finally, Sei Investments Co. lifted its stake in shares of DaVita by 21.3% in the first quarter. Sei Investments Co. now owns 41,952 shares of the company’s stock worth $5,790,000 after buying an additional 7,371 shares in the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.